Furthermore, ovarian carcinoma cells isolated from the ascites of a relapsed ovarian cancer patient initially responsive to taxanes, exhibited markedly reduced PRP4K expression compared to the primary tumour and correlated with taxane resistant disease (Corkery et al., 2015b). This evidence concerns the gene PRP4K and neoplasm.